Control of heart rate versus rhythm in rheumatic atrial fibrillation: A randomized study

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 9, Issue 2, 2004, Pages 65-73

  Vora, Amit ^a   Karnad, Dilip ^a   Goyal, Venkat ^a   Naik, Ajay ^a   Gupta, Anup ^a   Lokhandwala, Yas ^a   Kulkarni, Hema ^a   Singh, Bramah N ^b,c  

^a KEM HOSPITAL   (India)

^b UCLA MEDICAL CENTER   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Amiodarone; Direct current cardioversion; Rheumatic heart disease; Sinus rhythm; Ventricular rate

Indexed keywords

AMIODARONE; ATENOLOL; DIGOXIN; DILTIAZEM; MIDAZOLAM; PLACEBO; PROPOFOL; SEDATIVE AGENT;

ADULT; ARTICLE; BLEEDING; BRADYCARDIA; CARDIOVASCULAR DISEASE; CARDIOVERSION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIRECT CURRENT; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART VALVE PROSTHESIS; HOSPITALIZATION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC HEART DISEASE; SCORING SYSTEM; SINUS RHYTHM; THROMBOSIS; TREATMENT OUTCOME;

ADULT; AMIODARONE; ATRIAL FIBRILLATION; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; MALE; PROSPECTIVE STUDIES; RHEUMATIC HEART DISEASE;

EID: 4043172908     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840400900201     Document Type: Article

References (26)

1. Peterson P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomized trial of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK trial. Lancet 1:175-179, 1989
2. The Boston area anticoagulation trial for atrial fibrillation (BAATAF). The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Eng J Med 323:1505-1511, 1990
3. Connolly SJ, Laupacis A, Gent M, et al. Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardiol 18:349-355, 1991
4. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 84:527-539, 1991
5. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. N Eng J Med 327:1406-1412, 1992
6. Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: The Framingham Study. N Engl J Med 306(17):1018-1022, 1982
7. Alpert JS, Petersen P, Godtfredsen J. Atrial fibrillation: Natural history, complications, and management. Annu Rev Med 39:41-52, 1988
8. Atrial fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825-1833, 2002
9. Furberg CD, Psaty BM, Manslio TA, et al. Prevalence of atrial fibrillation in elderly subjects (The Cardiovascular Health Study). Am J Cardiol 74:236-241, 1994
10. Diker E, Aydogdu S, Ozdemir M, et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart discase. Am J Cadiol 77 (1):96-98, 1996
11. Donahue TP, Conti JB. Atrial fibrillation: Rate control versus maintenance of sinus rhythm. Curr Opin Cardiol 16 (1):46-53, 2001
12. Hohnloser SH, Kuck KH, Lilienthal J, et al. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomized trial. Lancet 356:1789-1794, 2000
13. Singh BN. Atrial Fibrillation Follow-up Investigation of Rhythm Management: AFFIRM Trial Outcomes. What might be their implications for arrhythmia control? J Cardiovasc Pharmacol Therapeut 7:131-133, 2002
14. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 342:913-920, 2000
15. Chun SH, Sager PT, Stevenson WG, et al. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 76:47-50, 1995
16. Kochiadakis GE, Igoumenidis NE, Marketou ME, et al. Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol 81(8):995-998, 1998
17. Eugene Braunwald. Valvular heart disease. In Heart Disease: a Textbook of Cardiovascular Medicine. 6th edition, WB Saunders Co. pp 1649; 2001
18. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 128:639-647, 1998
19. Lipkin DP, Frenneaux M, Stewart R, et al. Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm. Br Heart J 59:572-577, 1988
20. Van Gelder IC, Crijns HJGM, Blanksma PK, et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol 72:560-566, 1993
21. Ueshima K, Myers J, Morris CK, et al. The effect of cardioversion on exercise capacity in patients with atrial fibrillation. Am Heart J 126:1021-1024, 1993
22. Singh BN, Singh SN, Reda D, et al. Antiarrhythmic therapy in maintaining stability of sinus rhythm in Atrial Fibrillation-Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T). A Veterans Affairs Cooperative Study. New Engl J Med (submitted)
23. Patwardhan AM, Dave HH, Tamhane AA, et al. Intraoperative radiofrequency microbipolar coagulation to replace incisions of maze III procedure for correcting atrial fibrillation in patients with rheumatic valvular disease. Eur J Cardiothorac Surg 12 (4):627-633, 1997
24. Jatene MB, Marcial MB, Tarasoutchi F, et al. Influence of the maze procedure on the treatment of rheumatic atrial fibrillation-evaluation of rhythm control and clinical outcome in a comparative study. Eur J Cardiothorac Surg 17(2):117-124, 2000
25. Kim KB, Cho KR, Sohn DW, et al. The Cox-Maze III procedure for atrial fibrillation associated with rheumatic mitral valve disease. Ann Thorac Surg 68(3):799-803, 1999
26. Brodsky MA, Allen BJ, Walker CJ 3rd, et al. Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium. Am J Cardiol 60(7):572-575, 1987